Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel and Carboplatin with Radiation for Stage III NSCLC
NCT00544648Phase 2Terminated
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Nov 2007
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Vanderbilt-Ingram Cancer Center. Started Nov 2007; status: terminated.
02
Drugs
paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00544648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544648.